Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
suggesting this pathway may be a useful therapeutic target in inflammatory diseases such as asthma
They are designated at type I (slow twitch) and type II (fast twitch)
In the cytoplasm
patent Anti-Nav1
including myofibril necrosis in myopathies and in myocardial ischemia
Anti-human VEGFR1 / FLT1 (Abbott patent Anti-Flt1 Biosimilar) Size:1 mg suggesting this pathway may beApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name VEGFR1 FLT1 Target Uniprot P17948 Overview Catalog# BIO0411SM Product Name Anti human VEGFR1 FLT1 (Abbott patent Anti Flt1 Biosimilar) Specifications Conjugation None Clone# Abbott patent Anti Flt1 Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with
US$ 80.04
US$ 102.99
US$ 34.27
US$ 42.74
